HealthDay – THURSDAY, Jan. 28 (HealthDay News) — High-risk breast cancer
patients with HER2-positive tumors benefit from receiving the targeted
therapy Herceptin while undergoing chemotherapy, new research shows.
Read full article…

Other Headlines

• From the desk of [your news outlet] and Scribd
• Sports hub plan for school site (BBC News)
• Suspect in NC slaying of family of 4 dead in Utah (AP)
• AP source: Dodgers, Ramirez reach agreement (AP)
• Hurricane Bill’s winds weaken as it nears US (AP)
• Action Figures, Artists and Dinosaurs—Day-cationing in Cleveland
• Sam’s Club cuts 11,200 jobs, 10 percent of workforce